Cargando…
Bringing Preventive RSV Monoclonal Antibodies to Infants in Low- and Middle-Income Countries: Challenges and Opportunities
Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory tract infections (LRTIs) in infants. Most deaths occur in infants under 3 months old, and those living in low and middle-income countries (LMICs). There are no maternal or infant RSV vaccines currently approved. An RSV...
Autores principales: | Ananworanich, Jintanat, Heaton, Penny M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473431/ https://www.ncbi.nlm.nih.gov/pubmed/34579198 http://dx.doi.org/10.3390/vaccines9090961 |
Ejemplares similares
-
1633. Willingness to receive maternal RSV vaccine and infant monoclonal RSV antibody
por: Gidengil, Courtney, et al.
Publicado: (2023) -
Clinical and Regulatory Challenges and Opportunities for Monoclonal Antibodies in Low- and Middle-Income Countries: Lessons from COVID-19 and Beyond
por: Gieber, Lisa, et al.
Publicado: (2023) -
Prices of second-line antiretroviral treatment for middle-income countries inside versus outside sub-Saharan Africa
por: Simmons, Bryony, et al.
Publicado: (2014) -
Clinical emergency care research in low-income and middle-income countries: opportunities and challenges
por: Aluisio, Adam R, et al.
Publicado: (2019) -
Global psycho‐oncology in low middle‐income countries: Challenges and opportunities
por: Dunn, Jeff, et al.
Publicado: (2023)